PepKon

📍 Paris, France🗓 Founded 2022👥 5 employees💰 Last funded Jan 2022
Biotechnology
LinkedIn
PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in PepKon?
PepKon has 1 investors on record on gritt.io, including 1 early-stage backers.
When did PepKon last raise funding?
The most recent investment in PepKon recorded on gritt.io was in January 2022.
When was PepKon founded?
PepKon was founded in 2022.
What industry is PepKon in?
PepKon operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is PepKon based?
PepKon is headquartered in Paris, France.